Form 4 holding
10%+ Owner
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 5,313,261
- Estimated value
- $38,308,611
- Report date
- 02 Apr 2026
- Price
- $7.21
- Ownership
- as trustee
Elizabeth Hoge
Insider Reports History
- Location
- Washington, DC
- Signature
- /s/ Murat Kalayoglu, Authorized Person
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Elizabeth Hoge:
Form 4 holding
10%+ Owner
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 506,999
- Estimated value
- $3,655,462
- Report date
- 02 Apr 2026
- Price
- $7.21
- Ownership
- by spouse
Form 4 holding
10%+ Owner
Cartesian Therapeutics, Inc.
- Security class
- Series A Non-Voting Convertible Preferred Stock
- Shares / value
- 33,662
- Estimated value
- Report date
- 02 Apr 2026
- Price
- Ownership
- as trustee
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Elizabeth Hoge
4
RNAC
Cartesian Therapeutics, Inc.
- Report period
- 02 Apr 2026
- Transactions
- 2
- Transaction value
- $0
- Filing time
- 06 Apr 2026, 16:28
- Role
- 10%+ Owner
- Next action
- Open filing details
4
RNAC
Cartesian Therapeutics, Inc.
- Report period
- 11 Oct 2024
- Transactions
- 2
- Transaction value
- $0
- Filing time
- 15 Oct 2024, 16:43
- Role
- 10%+ Owner
- Next action
- Open filing details
4
RNAC
Cartesian Therapeutics, Inc.
- Report period
- 08 Apr 2024
- Transactions
- 4
- Transaction value
- $0
- Filing time
- 10 Apr 2024, 16:20
- Role
- 10%+ Owner
- Next action
- Open filing details
3
RNAC
Cartesian Therapeutics, Inc.
- Report period
- 13 Nov 2023
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 17 Nov 2023, 09:51
- Role
- 10%+ Owner
- Next action
- Open filing details